Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

NCT07486960 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriatic Arthritis

Interventions

DRUG: Tulisokibart
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC